Congress demands answers on mysterious ALS surge in veterans
H.R. 6001 — Veterans with ALS Reporting Act · Filed by Jason Crow (D-CO) · 9 cosponsors · Introduced Nov 10, 2025 · Markup held
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the Secretary of Veterans Affairs to submit a report within one year on the incidence and prevalence of ALS in veterans, including an assessment of current VA and CDC resources, identification of gaps, and strategies to reduce ALS risk and expand clinical trial access for affected veterans. The VA must then track ALS prevalence using the CDC registry and submit updates every three years thereafter.
Why we flagged it
The bill's sole operative mechanism is a requirement for federal agencies to report on ALS prevalence in veterans and develop risk-reduction strategies. It is a transparency and accountability measure, not a spending bill, regulatory change, or private benefit.
What the text implies
- Establishing a formal tracking mechanism via CDC registry may create the first comprehensive epidemiological baseline for ALS in the veteran population, potentially revealing previously undocumented clusters or environmental/occupational risk factors specific to military service.
- The mandate to develop clinical-trial pathways could accelerate veteran enrollment in ALS research, improving data quality for drug trials and potentially accelerating FDA approval timelines for ALS therapeutics.
The full analysis lists 3 implications of this text.
Who it affects
The bill mandates transparency and data collection on a serious disease affecting veterans, identifies resource gaps, and directs development of risk-reduction and clinical-trial strategies—all at no apparent cost to veterans or the public. It creates accountability for federal agencies to address a documented health crisis in the veteran population.